Jiong Wu, MD, PhD, discusses the significance of studying iza-bren in a phase 3 setting in unresectable, locally advanced or metastatic TNBC.
Jiong Wu, MD, PhD
Advertisement
Jiong Wu, MD, PhD, is a distinguished professor at Fudan University and vice president of the Fudan University Shanghai Cancer Center
Articles by Jiong Wu, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC
2
FDA Approves Adjuvant Belzutifan Plus Pembrolizumab in ccRCC
3
CARTITUDE-4 Analysis Shows Bridging Therapy Response Predicts Cilta-Cel Benefit in Lenalidomide-Refractory Myeloma
4
Topline LAGOON Results Show Missed OS End Point With Lurbinectedin in Relapsed SCLC
5